Association between the use of protease inhibitors in highly active antiretroviral therapy and incidence of diabetes mellitus and/or metabolic syndrome in HIV-infected patients: A systematic review and meta-analysis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association between the use of protease inhibitors in highly active antiretroviral therapy and incidence of diabetes mellitus and/or metabolic syndrome in HIV-infected patients: A systematic review and meta-analysis
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF STD & AIDS
Volume 29, Issue 5, Pages 443-452
Publisher
SAGE Publications
Online
2017-09-28
DOI
10.1177/0956462417732226
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Improvement in Insulin Sensitivity and Dyslipidemia in Protease Inhibitor-Treated Adult Male Patients After Switch to Atazanavir/Ritonavir
- (2016) Anthony J. Busti et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Impact of randomized antiretroviral therapy initiation on glucose metabolism
- (2014) Kristine Mace Erlandson et al. AIDS
- Metabolic Syndrome, Diabetes, and Cardiovascular Risk in HIV
- (2014) Linda M. Nix et al. Current HIV/AIDS Reports
- A Comprehensive Review on Metabolic Syndrome
- (2014) Jaspinder Kaur Cardiology Research and Practice
- HIV Protease Inhibitors Disrupt Lipid Metabolism by Activating Endoplasmic Reticulum Stress and Inhibiting Autophagy Activity in Adipocytes
- (2013) Beth S. Zha et al. PLoS One
- Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study
- (2012) Kathy Petoumenos et al. Journal of the International AIDS Society
- The prevalence and pathogenesis of diabetes mellitus in treated HIV-infection
- (2011) Il Joon Paik et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Molecular mechanisms for insulin resistance in treated HIV-infection
- (2011) Paul W. Hruz BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Prevention of HIV-1 Infection with Early Antiretroviral Therapy
- (2011) Myron S. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- HIV Protease Inhibitors Act as Competitive Inhibitors of the Cytoplasmic Glucose Binding Site of GLUTs with Differing Affinities for GLUT1 and GLUT4
- (2011) Richard C. Hresko et al. PLoS One
- Highly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and update
- (2010) Reuben Granich et al. Current Opinion in HIV and AIDS
- HIV infection and the risk of diabetes mellitus
- (2009) Adeel A Butt et al. AIDS
- Metabolic syndrome associated with HIV and highly active antiretroviral therapy
- (2009) Giuseppe Barbaro et al. Current Diabetes Reports
- Early Antiretroviral Therapy Reduces AIDS Progression/Death in Individuals with Acute Opportunistic Infections: A Multicenter Randomized Strategy Trial
- (2009) Andrew R. Zolopa et al. PLoS One
- Metabolic changes associated with antiretroviral therapy in HIV-positive patients
- (2009) Sabrina Esteves de Matos Almeida et al. REVISTA DE SAUDE PUBLICA
- HIV therapy, metabolic syndrome, and cardiovascular risk
- (2008) Vivian Pao et al. Current Atherosclerosis Reports
- Incidence and Risk Factors for New-Onset Diabetes in HIV-Infected Patients: The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study
- (2008) S. De Wit et al. DIABETES CARE
- Metabolic Syndrome and Incident Diabetes: Current state of the evidence
- (2008) E. S. Ford et al. DIABETES CARE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search